AvePoint, Inc. (NASDAQ:AVPT – Get Free Report) insider Brian Brown sold 3,500 shares of the business’s stock in a transaction dated Friday, October 16th. The stock was sold at an average price of $15.20, for a total transaction of $53,200.00. Following the transaction, the insider owned 332,210 shares in the company, valued at approximately $5,049,592. This trade represents a 1.04% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Brian Michael Brown also recently made the following trade(s):
- On Tuesday, October 20th, Brian Brown sold 72,606 shares of AvePoint stock. The stock was sold at an average price of $15.26, for a total transaction of $1,107,967.56.
- On Tuesday, October 6th, Brian Brown sold 28,894 shares of AvePoint stock. The stock was sold at an average price of $15.15, for a total transaction of $437,744.10.
- On Wednesday, September 30th, Brian Brown sold 10,000 shares of AvePoint stock. The shares were sold at an average price of $14.11, for a total transaction of $141,100.00.
- On Wednesday, September 23rd, Brian Brown sold 10,000 shares of AvePoint stock. The shares were sold at an average price of $13.07, for a total transaction of $130,700.00.
- On Thursday, August 27th, Brian Brown sold 60,000 shares of AvePoint stock. The shares were sold at an average price of $14.20, for a total value of $852,000.00.
- On Monday, August 24th, Brian Brown sold 10,000 shares of AvePoint stock. The shares were sold at an average price of $13.30, for a total value of $133,000.00.
- On Wednesday, July 29th, Brian Brown sold 5,176 shares of AvePoint stock. The stock was sold at an average price of $13.06, for a total value of $67,598.56.
- On Tuesday, July 28th, Brian Brown sold 4,824 shares of AvePoint stock. The stock was sold at an average price of $13.08, for a total value of $63,097.92.
AvePoint Trading Up 3.3%
Shares of AVPT stock opened at $15.23 on Wednesday. The company has a market cap of $3.22 billion, a price-to-earnings ratio of 47.60 and a beta of 1.17. The stock has a 50 day simple moving average of $13.69 and a 200-day simple moving average of $11.99. AvePoint, Inc. has a 12-month low of $8.84 and a 12-month high of $15.49.
AvePoint (NASDAQ:AVPT – Get Free Report) last posted its quarterly earnings results on Thursday, August 6th. The company reported $0.12 EPS for the quarter, beating the consensus estimate of $0.08 by $0.04. AvePoint had a return on equity of 15.97% and a net margin of 15.33%. The business had revenue of $124.50 million during the quarter, compared to analysts’ expectations of $121.38 million. On average, equities analysts forecast that AvePoint, Inc. will post 0.25 earnings per share for the current fiscal year.
Analyst Upgrades and Downgrades
A number of research firms have commented on AVPT. Weiss Ratings raised AvePoint from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, August 11th. Stephens boosted their target price on shares of AvePoint from $16.00 to $17.00 and gave the stock an “overweight” rating in a research report on Monday, September 21st. TD Cowen upped their price target on shares of AvePoint from $14.00 to $15.00 and gave the stock a “buy” rating in a research note on Friday, August 7th. Scotiabank upped their price target on shares of AvePoint from $12.00 to $15.00 and gave the stock a “sector outperform” rating in a research note on Friday, August 7th. Finally, Cantor Fitzgerald reiterated an “overweight” rating on shares of AvePoint in a report on Tuesday, September 22nd. Ten investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $16.25.
View Our Latest Analysis on AvePoint
Institutional Investors Weigh In On AvePoint
A number of large investors have recently bought and sold shares of AVPT. Wellington Management Group LLP raised its holdings in shares of AvePoint by 106.7% in the second quarter. Wellington Management Group LLP now owns 2,776,579 shares of the company’s stock worth $31,125,000 after acquiring an additional 1,433,299 shares during the last quarter. Dimensional Fund Advisors LP lifted its position in shares of AvePoint by 25.7% in the first quarter. Dimensional Fund Advisors LP now owns 3,264,082 shares of the company’s stock valued at $31,040,000 after acquiring an additional 666,422 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund lifted its position in shares of AvePoint by 25.0% in the first quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 2,675,587 shares of the company’s stock valued at $25,445,000 after acquiring an additional 535,015 shares in the last quarter. Renaissance Technologies LLC lifted its position in shares of AvePoint by 16.4% in the first quarter. Renaissance Technologies LLC now owns 2,580,153 shares of the company’s stock valued at $24,537,000 after acquiring an additional 363,200 shares in the last quarter. Finally, SG Americas Securities LLC boosted its stake in shares of AvePoint by 335.2% during the first quarter. SG Americas Securities LLC now owns 2,391,696 shares of the company’s stock valued at $22,745,000 after acquiring an additional 1,842,124 shares during the last quarter. Institutional investors and hedge funds own 44.49% of the company’s stock.
About AvePoint
AvePoint, Inc (NASDAQ:AVPT) is a data management and governance software company that helps organizations protect, manage and modernize information across cloud, hybrid and on-premises environments. Its solutions are designed primarily for collaboration and productivity platforms, including Microsoft 365, SharePoint, Dynamics 365 and Salesforce.
The company’s product portfolio includes cloud backup and recovery, data migration, governance, security, compliance and administration tools.
Featured Articles
- Five stocks we like better than AvePoint
- Aurora Rejects Curaleaf’s Higher Bid, But the Takeover Fight Isn’t Over
- Centrus Energy Is Building a Nuclear Fuel Powerhouse—Why Is Its Stock Struggling?
- Halliburton Gains Traction: Multiyear Upcycle Ahead
- Meta Platforms’ AI Comeback Faces an Earnings Test—And a $10 Billion Charge
Receive News & Ratings for AvePoint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AvePoint and related companies with MarketBeat.com's FREE daily email newsletter.
